05/08/2024
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
05/08/2024
Aug 5, 2024, 02:16 |
Blog
Neeraj Agarwal: Biomarker based treatment of bladder cancer
Neeraj Agarwal shared a post on X: "Biomarker based treatment of bladder cancer. Enjoyed the…
Aug 5, 2024, 01:55 |
Societies
Scientific Committees at the ESMO Congress 2024
The ESMO Congress is a globally influential oncology platform that brings together clinicians, researchers, patient…
Aug 5, 2024, 01:42 |
Blog
Michael Harrison: Awesome to present on favorable risk mRCC at WorldGU24
Michael Harrison, GU medical oncologist at Duke Cancer Institute, shared a post on X: Awesome…
Aug 5, 2024, 01:37 |
Blog
Jasper de Boer: Bringing back effective yet unprofitable drugs underscores a significant obstacle in the healthcare system
Jasper de Boer, Funding and Partnership Manager at ANZCHOG, shared a post on LinkedIn: "Bringing…
Aug 5, 2024, 01:27 |
Blog
Jorge Cortes: Blood Global Hematology will be open for submissions soon
Jorge Cortes, Director of the Georgia Cancer Center, shared a post on X: "Blood Global…
Aug 5, 2024, 00:28 |
Insight
Jennifer Marks: Lung fluid cytology sensitivity for malignancy varies by histology?
Jennifer Marks, Thoracic Oncologist at Georgetown Lombardi, shared a post on X: "Did you know…
Aug 5, 2024, 00:16 |
Blog
Narjust Florez: I love and hate this post at the same time
Narjust Florez shared a post by Fumiko Ladd Chino, adding: "I love and hate this…
Aug 5, 2024, 00:11 |
Insight
5 year outcomes of SOC Axicabtagene Ciloleucel
Graham Collins, Associate Professor of Haematology and lymphoma specialist at Oxford Cancer and Haematology centre,…
All:
8
Posts:
1 - 10
A Manifesto to Improve Cancer Care in Conflict-Affected Areas: The Lancet
Why does Lionel Messi donate so much to charity?
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
Facebook
RSS Feed
Twitter
Linkedin
Youtube